Premium Resmetirom API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Resmetirom (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Thyroid Hormone Receptor-Beta (THR-β) Agonist

Indications: Non-Alcoholic Steatohepatitis (NASH) / Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Resmetirom distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Resmetirom is a highly selective, liver-directed, orally active small-molecule Active Pharmaceutical Ingredient (API). In endocrine and hepatic pharmacology, it is classified as a thyroid hormone receptor-beta (THR-β) agonist. For pharmaceutical manufacturers expanding into metabolic and hepatic disease portfolios, this API represents a foundational raw material for addressing advanced liver pathologies.

The pharmacological efficacy of Resmetirom relies on its high selectivity for the THR-β receptor. Thyroid hormones natively regulate lipid metabolism within the liver. However, administering systemic thyroid hormones causes severe off-target cardiac and systemic effects mediated by the thyroid hormone receptor-alpha (THR-α). Resmetirom is engineered to selectively bind to THR-β, which is the predominant receptor isoform expressed in human liver tissue.

At the cellular level, the API works by stimulating the liver to break down and oxidize fatty acids. This selective activation directly accelerates hepatic lipid metabolism (beta-oxidation), which effectively reduces liver fat accumulation, mitigates lipotoxicity, and lowers systemic lipid levels (including LDL cholesterol and triglycerides). By decreasing hepatic lipotoxicity, the active ingredient interrupts the chronic inflammatory and fibrotic cascades that characterize Non-Alcoholic Steatohepatitis (NASH).

For pharmaceutical formulation scientists, integrating this API enables the development of first-in-class, liver-targeted oral therapeutics. In commercial manufacturing, this active ingredient is typically formulated into immediate-release oral solid tablets (standardly in 60 mg, 80 mg, and 100 mg dosages).

Sourcing Resmetirom in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced hepatic therapeutics requires a highly resilient and traceable raw material pipeline. Procuring novel metabolic APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and complex regulatory compliance. Sourcing Resmetirom Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether your facility requires a pilot batch for R&D or you are scaling up a high-volume Resmetirom api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without line stoppages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during dry blending and tablet compression processes.

Technical Specifications for QA & R&D

The Resmetirom API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 2-[3,5-dichloro-4-[(6-oxo-5-propan-2-yl-1H-pyridazin-3-yl)oxy]phenyl]-3,5-dioxo-1,2,4-triazine-6-carbonitrile
• CAS Number: 920509-32-6
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C17H12Cl2N6O4
• Molecular Weight: 435.22 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling, excipient compatibility, and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

Resmetirom is a pharmacologically active compound targeting metabolic receptors. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent chemical degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or powered air-purifying respirators (PAPR), chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, micronization, milling, and blending stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure containment isolators to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.